UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pharmaceutical Industry Payments to Medical Oncologists in the Netherlands: Trends and Patterns Provided by an Open-Access Transparency Data Set

JCO oncology practice, 2024-06, Vol.20 (6), p.843-851

2024

Volltextzugriff (PDF)

Design issues with lutetium-177 PSMA-617 registration studies that bias the outcome of the experimental arm reflect an increasing misalignment of contemporary oncology trials with true patient benefit

BJC Reports, 2024-06, Vol.2 (1), p.1-4, Article 45

2024

Volltextzugriff (PDF)

Plasma annexin A5 and microparticle phosphatidylserine levels are elevated in sickle cell disease and increase further during painful crisis

Biochemical and biophysical research communications, 2009-12, Vol.390 (1), p.161-164

2009

Volltextzugriff (PDF)

Plasma levels of asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, are elevated in sickle cell disease

Annals of hematology, 2005-05, Vol.84 (5), p.282-286

2005

Volltextzugriff (PDF)

An unusual craving

Netherlands journal of medicine, 2015-02, Vol.73 (2), p.96

2015

Volltextzugriff (PDF)

Plasma asymmetric dimethylarginine concentrations in sickle cell disease are related to the hemolytic phenotype

Blood cells, molecules, & diseases, 2010-04, Vol.44 (4), p.229-232

2010

Volltextzugriff (PDF)

No association of the hypercoagulable state with sickle cell disease related pulmonary hypertension

Haematologica (Roma), 2008-05, Vol.93 (5), p.e42-e44

2008

Volltextzugriff (PDF)

Extremely slow methotrexate elimination in a patient with t(9;22) positive acute lymphoblastic leukemia treated with imatinib

American journal of hematology, 2008-09, Vol.83 (9), p.757-758

2008

Volltextzugriff (PDF)

Increased Serum Levels of Anti-Angiogenic Factors Soluble fms-Like Tyrosine Kinase and Soluble Endoglin in Sickle Cell Disease

Acta haematologica, 2008-01, Vol.120 (3), p.130-133

2008

Volltextzugriff (PDF)

Elevated Circulating Stromal-Derived Factor-1 Levels in Sickle Cell Disease

Acta haematologica, 2009-01, Vol.122 (1), p.64-69

2009

Volltextzugriff (PDF)

Folate status assessment and folic acid supplements in sickle cell disease

Journal of pediatric hematology/oncology, 2001-11, Vol.23 (8), p.548

2001

Volltextzugriff (PDF)

Plasma homocysteine levels in sickle cell disease and the need for folate supplementation

Journal of pediatric hematology/oncology, 2000-03, Vol.22 (2), p.184-185

2000

Volltextzugriff (PDF)

An unusual craving

The Netherlands journal of medicine, 2015, Vol.73 (2), p.96-96

2015

Volltextzugriff (PDF)

An analytical view of the BJH publication of ‘a clinician's view of voxelotor’

British journal of haematology, 2023-03, Vol.200 (6), p.e56-e57

2023

Volltextzugriff (PDF)

An urgent call to raise the bar in oncology

British journal of cancer, 2021-11, Vol.125 (11), p.1477-1485

2021

Volltextzugriff (PDF)

Nucleosomes and neutrophil activation in sickle cell disease painful crisis

Haematologica (Roma), 2013-11, Vol.98 (11), p.1797-1803

2013

Volltextzugriff (PDF)

Contemporary oncology trials, drug approvals and the physician-patient relationship

Lancet Regional Health - Americas (Online), 2022-07, Vol.11, p.100247, Article 100247

2022

Volltextzugriff (PDF)

Pharmaceutical company funding of cancer patient advocacy organizations in the Netherlands

Journal of cancer policy, 2024-09, Vol.41, p.100493, Article 100493

2024

Volltextzugriff (PDF)

Trastuzumab Deruxtecan in HER2-Low Breast Cancer

The New England journal of medicine, 2022-09, Vol.387 (12), p.1143-1144

2022

Volltextzugriff (PDF)

Untoward global effects of current guideline formulation of stereotactic radiotherapy for symptomatic brain metastases by international medical societies

Lancet Regional Health - Americas (Online), 2023-09, Vol.25, p.100584-100584, Article 100584

2023

Volltextzugriff (PDF)

N-acetylcysteine reduces oxidative stress in sickle cell patients

Annals of hematology, 2012-07, Vol.91 (7), p.1097-1105

2012

Volltextzugriff (PDF)

N‐terminal pro‐B‐type natriuretic peptide, tricuspid jet flow velocity, and death in adults with sickle cell disease

American journal of hematology, 2015-04, Vol.90 (4), p.E75-E76

2015

Volltextzugriff (PDF)

Increased efflux of oxidized glutathione (GSSG) causes glutathione depletion and potentially diminishes antioxidant defense in sickle erythrocytes

Biochimica et biophysica acta, 2011-11, Vol.1812 (11), p.1412-1417

2011

Volltextzugriff (PDF)

Trastuzumab Deruxtecan in HER2-Low Breast Cancer

The New England journal of medicine, 2022-09, Vol.387 (12), p.1143-1146

2022

Volltextzugriff (PDF)

Association of asymmetric dimethylarginine with sickle cell disease-related pulmonary hypertension

Haematologica (Roma), 2008-09, Vol.93 (9), p.1410-1412

2008

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Aktive Filter

ThemaMedical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(37)
Berichte
(1)

Sprache

Englisch
(38)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pharmaceutical Industry Payments to Medical Oncologists in the Netherlands: Trends and Patterns Provided by an Open-Access Transparency Data Set

Design issues with lutetium-177 PSMA-617 registration studies that bias the outcome of the experimental arm reflect an increasing misalignment of contemporary oncology trials with true patient benefit

Plasma annexin A5 and microparticle phosphatidylserine levels are elevated in sickle cell disease and increase further during painful crisis

Plasma levels of asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, are elevated in sickle cell disease

An unusual craving

Plasma asymmetric dimethylarginine concentrations in sickle cell disease are related to the hemolytic phenotype

No association of the hypercoagulable state with sickle cell disease related pulmonary hypertension

Extremely slow methotrexate elimination in a patient with t(9;22) positive acute lymphoblastic leukemia treated with imatinib

Increased Serum Levels of Anti-Angiogenic Factors Soluble fms-Like Tyrosine Kinase and Soluble Endoglin in Sickle Cell Disease

Elevated Circulating Stromal-Derived Factor-1 Levels in Sickle Cell Disease

Folate status assessment and folic acid supplements in sickle cell disease

Plasma homocysteine levels in sickle cell disease and the need for folate supplementation

An unusual craving

An analytical view of the BJH publication of ‘a clinician's view of voxelotor’

An urgent call to raise the bar in oncology

Nucleosomes and neutrophil activation in sickle cell disease painful crisis

Contemporary oncology trials, drug approvals and the physician-patient relationship

Pharmaceutical company funding of cancer patient advocacy organizations in the Netherlands

Trastuzumab Deruxtecan in HER2-Low Breast Cancer

Untoward global effects of current guideline formulation of stereotactic radiotherapy for symptomatic brain metastases by international medical societies

N-acetylcysteine reduces oxidative stress in sickle cell patients

N‐terminal pro‐B‐type natriuretic peptide, tricuspid jet flow velocity, and death in adults with sickle cell disease

Increased efflux of oxidized glutathione (GSSG) causes glutathione depletion and potentially diminishes antioxidant defense in sickle erythrocytes

Trastuzumab Deruxtecan in HER2-Low Breast Cancer

Association of asymmetric dimethylarginine with sickle cell disease-related pulmonary hypertension

Aktive Filter

Suchergebnisse filtern